Neuroenhancement: Wisdom of the masses or "false phronesis"?

Clinical Pharmacology and Therapeutics

Volumn 88, Issue 4, 2010, Pages 459-461

  Larriviere, D ^a   Williams, M A ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; MODAFINIL; CENTRAL STIMULANT AGENT; NOOTROPIC AGENT;

COGNITION; CONSUMER ATTITUDE; CONSUMER HEALTH INFORMATION; COSMETIC INDUSTRY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG SAFETY; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL PRACTICE; MEMORY; NERVOUS SYSTEM FUNCTION; NEUROENHANCEMENT; NOTE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; DRUG EFFECTS;

CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; ETHICS, CLINICAL; HUMANS; NOOTROPIC AGENTS;

EID: 77957053536     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.140     Document Type: Note

References (12)

1. McCabe, S.E., Knight, J.R., Teter, C.J. & Wechsler, H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100, 96-106 (2005).
2. DeSantis, A.D., Webb, E.M. & Noar, S.M. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. J. Am. Coll. Health 57, 315-324 (2008).
3. Maher, B. Poll results: look whos doping. Nature 452, 674-675 (2008).
4. Chatterjee, A. The promise and predicament of cosmetic neurology. J. Med. Ethics 32, 110-113 (2006).
5. Talbot, M. Brain gain: the underground world of neuroenhancing drugs. The New Yorker, 32-43 (27 April 2009).
6. Greely, H., Sahakian, B., Harris, J., Kessler, R.C., Gazzaniga, M., Campbell, P. et al. Toward responsible use of cognitive-enhancing drugs by the healthy. Nature 456, 702-705 (2008).
7. Larriviere, D., Williams, M.A., Rizzo, M. & Bonnie, R.J. Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law, and Humanities Committee. Neurology 73, 1406-1412 (2009).
8. Chatterjee, A. Cosmetic neurology and cosmetic surgery: parallels, predictions, and challenges. Camb. Q. Healthc. Ethics 16, 129-137 (2007).
9. Forlini, C. & Racine, E. Autonomy and coercion in academic "cognitive enhancement" using methylphenidate: perspectives of key stakeholders. Neuroethics 2, 163-177 (2009).
10. Russo, M. Recommendations for the ethical use of pharmacologic fatigue countermeasures in the U.S. military. Aviat. Space Environ. Med. 78(5, Suppl.), B119-27 (2007).
11. de Jongh, R., Bolt, I., Schermer, M. & Olivier, B. Botox for the brain: enhancement of cognition, mood and prosocial behavior and blunting of unwanted memories. Neurosci. Biobehav. R. 32, 760-776 (2008).
12. Brennan, T. et al. Medical professionalism in the new millennium: a physician charter. Ann. Intern. Med. 136, 243-246 (2002).